JOHOR Baru City Council (MBJB) has announced the successful completion of a flood mitigation project in Kampung Oren, Ulu ...

India 10-year bond yield fell 0.41 per cent to 5.89 after trading in 5.87-5.91 range NEW DELHI: The Nifty Pharma index traded ...

Peter Bains, Group CEO of Biocon, talks about India's budget, and the impact of its plans to cut or remove duties on ...

Following the presentation of the Union Budget 2025, several prominent industry leaders have shared their reactions, offering ...

FM’s intent to give relief to patients will be realised more with GST exemption and will make a huge impact, considering that in India 80% of healthcare expenses are out of pocket, writes Biocon ...

Biocon plans to list its biosimilars business by March 2026, targeting a double-digit market share in the U.S. with five new ...

Hyderabad: Biopharma major Biocon plans to introduce five new biosimilars in the United States in the new fiscal year, ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with the ...

Biocon reported a net profit of Rs 25 crore for Q3 FY25, down from Rs 660 crore the previous year, mainly due to exceptional gains last year. The company's income was Rs 3,821 crore. Growth in ...

The FDA accepted applications for a golimumab biosimilar, while Samsung Biologics reported record sales, and a Japanese ...

Kiran Mazumdar-Shaw, Chairperson of major drugmaker Biocon Ltd., urged the government to eliminate tax on drugs for cancer treatment and for chronic and rare diseases, ahead of the budget 2025 ...